This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
AB InBev (BUD) Stays on Growth Track on Ongoing Initiatives
by Zacks Equity Research
AB InBev (BUD) witnesses positive business momentum on pricing actions, ongoing premiumization and other revenue-management initiatives.
Can FEMSA (FMX) Stock Regain Momentum on Effective Strategies?
by Zacks Equity Research
FEMSA (FMX) looks poised for long-term growth on its FEMSA forward strategy, digital initiatives, business expansion endeavors, and continued strength in OXXO Mexico and OXXO Gas.
Bet on These 4 Low-Beta Stocks to Navigate Market Uncertainty
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. The Vita Coco (COCO), Seanergy (SHIP), Arcos Dorados (ARCO) & Palomar (PLMR) are well-poised to gain.
Constellation Brands' (STZ) Strong Brands Help Retain Momentum
by Zacks Equity Research
Constellation Brands (STZ) continues to witness momentum on strength in the beer business, as well as premiumization and expansion efforts.
The Vita Coco and Xerox have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
The Vita Coco and Xerox have been highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Vita Coco (COCO)
by Bryan Hayes
Earnings estimates are on the rise for this leading producer of coconut water.
Can Pilgrim's Pride's (PPC) Growth Efforts Help Keep Momentum?
by Zacks Equity Research
Pilgrim's Pride's (PPC) strategic focus on engaging key customers, investing in brand building and enhancing operational efficiency positions it well to overcome the volatile nature of market conditions.
Molson Coors' (TAP) Premium Brands Place It Well: Apt to Hold?
by Zacks Equity Research
Molson Coors (TAP) looks steady on efforts to boost market share through innovation and premiumization amid rising inflationary cost pressures.
Clorox (CLX) Benefits From Strategic Actions Amid High Costs
by Zacks Equity Research
Clorox (CLX) is poised for significant expansion by focusing on the implementation of its pricing strategy and cost saving initiatives amid cost-related hurdles.
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These are Vita Coco Company (COCO), AMC Entertainment (AMC), Hyperfine (HYPR), Aptevo Therapeutics (APVO) and CLEAR Secure (YOU).
Zacks Market Edge Highlights: Wingstop, Super Micro Computer, Medpace, Him & Hers Health and Vita Coco
by Zacks Equity Research
Wingstop, Super Micro Computer, Medpace, Him & Hers Health and Vita Coco are part of the Zacks Market Edge blog.
5 Top Ranked Strong Buy Growth Stocks for 2024
by Tracey Ryniec
Get double digit earnings growth this year.
Here's Why Newell Brands' (NWL) Strategic Efforts Seem Encouraging
by Zacks Equity Research
Newell Brands' (NWL) new operating model, innovation, brand building and margin expansion have been driving growth amid a challenging macroeconomic environment.
Is Vita Coco Company (COCO) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Vita Coco Company, Inc. (COCO) and Carlsberg AS (CABGY) have performed compared to their sector so far this year.
Campbell Soup (CPB) Gains on Robust Strategies Amid High Costs
by Zacks Equity Research
Campbell Soup's (CPB) supply-chain initiatives, effective marketing, innovations and disciplined promotional activities have been driving growth amid a volatile operating landscape.
Do Boston Beer's (SAM) Strategies Position It Well Among Peers?
by Zacks Equity Research
Boston Beer (SAM) is likely to retain its long-standing market position with its solid brand portfolio, the Beyond Beer strategy, innovation and pricing actions amid a troubled hard seltzer category.
Productivity Actions Drive Diageo (DEO) Amid Cost Woes
by Zacks Equity Research
Diageo (DEO) progresses well on its new productivity commitment, targeting productivity savings of $2 billion from fiscal 2025 to 2027. Will this continue to aid its performance amid high costs?
Procter & Gamble's (PG) Focus on Productivity Plans Bodes Well
by Zacks Equity Research
Procter & Gamble (PG) is on track with its productivity and cost-saving plans, as reflected by its performance. PG enjoys cost savings and efficiency improvements across all facets of the business.
Momentum in Beer Business to Drive Constellation Brands (STZ)
by Zacks Equity Research
Constellation Brands (STZ) has been benefiting from the momentum in the beer business, driven by strength in its Modelo Especial, the Modelo Chelada, Corona Extra and Pacifico brands.
B&G Foods (BGS) Q1 Earnings & Sales Lag Estimates, Volumes Soft
by Zacks Equity Research
B&G Foods' (BGS) first-quarter results demonstrate consistent margins amid the challenges posed by foodservice trends and heightened promotional spending.
AB InBev (BUD) Surpasses Earnings & Revenue Estimates in Q1
by Zacks Equity Research
AB InBev (BUD) Q1 results reflect gains from strong revenue per hl growth on pricing actions, premiumization and revenue-management initiatives. Accelerated digital transformation also aids results.
Zacks.com featured highlights include SkyWest, Powell Industries, Minerals Technologies, The Vita Coco and Tenet Healthcare
by Zacks Equity Research
SkyWest, Powell Industries, Minerals Technologies, The Vita Coco and Tenet Healthcare have been highlighted in this Screen of The Week article.
5 Strong Picks to Ride the Wave of Relative Price Strength
by Nilanjan Choudhury
SKYW, POWL, MTX, COCO and THC are five stocks with explosive relative price strength.
Monster Beverage's (MNST) Q1 Earnings Miss, Sales Rise Y/Y
by Zacks Equity Research
Monster Beverage (MNST) sees strength in its energy drinks category. In addition, the company's expansion strategy bodes well.
Vita Coco Company (COCO) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Vita Coco Company (COCO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.